Guanshan Zhu

Medicine · Health Sciences

30h-index4.3kcitations93works4.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(36), Cancer Genomics and Diagnostics(20), Colorectal Cancer Treatments and Studies(13), Fibroblast Growth Factor Research(12), RNA modifications and cancer(10)

Publications90 total

Engineered Hypoimmunogenic iPSC-Derived Mesenchymal Stromal Cells Secreting High Levels of Functional FVIII Ameliorate the Hemophilia a Phenotype
SSRN Electronic Journal·2026Open Access
EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment
Lung Cancer·2024· 9 citedOpen Access
Supplementary Figure 2 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Figure 1 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Tables 1 - 4 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Figure 1 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Data from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Tables 1 - 4 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Figure Legend from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Data from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Figure 2 from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Supplementary Figure Legend from Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i>-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
2023Open Access
Abstract 558: Muti-gene ARMS PCR using both cfDNA and cfRNAin the supernatant of pleural effusion achieves rapid and accuracy driver gene mutations detection
Cancer Research·2021
Abstract 3136: A novel algorism evaluating dominant clonality in Chinese NSCLC patients with concomitant EGFR and ALK variation
Cancer Research·2021
Abstract 467: Detecting <i>ALK</i> rearrangement by RT-PCR: A superior approach to next generation sequencing
Cancer Research·2021
Abstract 419: Presence of pulmonary tuberculosis impair survival in advanced <i>EGFR</i> mutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor
Cancer Research·2021
Sputum cell‐free DNA: Valued surrogate sample for the detection of <i>EGFR</i> exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR‐TKIs
Cancer Medicine·2021· 9 citedOpen Access
Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC
Cancer Medicine·2021· 10 citedOpen Access
Refined Stratification Based on Baseline Concomitant Mutations and Longitudinal Circulating Tumor DNA Monitoring in Advanced EGFR-Mutant Lung Adenocarcinoma Under Gefitinib Treatment
Journal of Thoracic Oncology·2020· 33 citedOpen Access
Sputum Cell-Free DNA
Journal of Molecular Diagnostics·2020· 22 cited
page 1 of 5Next →

Frequent Co-authors

Qunsheng Ji(12), Xiaolu Yin(9), David Goldman(7), Xinying Su(7), Zhongzheng Zhu(7), Zhengwei Dong(6), Ziliang Qian(6), Yachao Lu(6), Robert H. Lipsky(5), Xin Ye(5), Paul R. Gavine(5), Matti Virkkunen(4), Li Liang(4), Jingchuan Zhang(4), Liang Xie(4), Yun Sun(4), Zhong-Zheng Zhu(4), Wen‐Ming Cong(4), Longina A. Akhtar(3), Julie Taubman(3)